Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Treatment resistance affects nearly half of all young people experiencing moderate-to-severe anxiety. In this 12-week open-label trial, patients received add-on CBD after noclinical improvement on therapy with CBT and/or antidepressant medication. There wasa more than 40% reduction in mean OASIS scores and no serious or unexpectedadverse events.
Pediatrics August 16th 2022
Psych Congress Network
In what is thought to be the largest study to date of any type of ketamine treatment, the findings revealed that, after four sessions, 89 percent of participants reported improvement in their depression and/or anxiety symptoms. On the PHQ-9 or GAD-7 scale, 63 percent of participants saw a 50% or greater improvement. PHQ-9 remission rates were 32.6 percent and GAD-7 remission rates were 31.3 percent. Furthermore, at the end of the four weeks, 62 percent of patients who had suicidal ideation prior to treatment reported no suicidal ideation.
Psychiatry August 8th 2022
MDLinx
Anxiety disorders are among the most common of psychiatric disorders, with estimates suggesting a lifetime prevalence in the US of approximately 32%. But development of new and effective treatments for anxiety disorders has lagged behind new treatments for other conditions such as major depressive disorder, bipolar disorder, and schizophrenia. This article reviews current treatment and their effectiveness, and highlights the emerging new hopefuls.
Family Medicine/General Practice July 26th 2022
JAMA Network
With fast symptom relief and reinforcing effects, benzodiazepines were once the gold standard for treating insomnia and anxiety. As opioids dominate headlines along with the public health crisis of drug overdose deaths, is it time to reconsider benzodiazepines as a course of treatment?
Psychiatry June 21st 2022
Cannabis use increases the likelihood that patients will develop several negative health conditions, such as insomnia, anxiety, psychosis, and depression. As such, cannabis use should be prescribed carefully by physicians.
Family Medicine/General Practice May 10th 2022
Healthgrades for Professionals
With 1 in 5 COVID-19 patients receiving a psychiatric diagnosis within 90 days of their COVID diagnosis, it’s obvious the pandemic is wreaking havoc on the population’s mental health, whether its anxiety disorders, insomnia, losing a loved one, losing a job, caring for the sick, or all of the above. Learn what you and your patients can do to protect and manage mental health during these trying times.
Family Medicine/General Practice March 23rd 2021